67 related articles for article (PubMed ID: 575493)
1. The action of creatinol 0-phosphate on the inotropic effect of isoprenaline in isolated rat atria and in anesthetized dogs.
Godfraind T; Ghysel-Burton J; Merlo L
Arzneimittelforschung; 1979; 29(9a):1465-7. PubMed ID: 575493
[TBL] [Abstract][Full Text] [Related]
2. Action of creatinol-O-phosphate on the contractility changes evoked by hypoxia and ischemia in rat isolated heart.
Godfraind T; Saleh MM
Arzneimittelforschung; 1984; 34(9):968-72. PubMed ID: 6542374
[TBL] [Abstract][Full Text] [Related]
3. Ionic changes evoked by isoprenaline in rat hearts in vivo and in vitro and their reduction by creatinol O-phosphate.
Godfraind T; Ghysel-Burton J; Sturbois X
Arzneimittelforschung; 1979; 29(9a):1468-70. PubMed ID: 575494
[TBL] [Abstract][Full Text] [Related]
4. An analysis of the reduction by creatinol O-phosphate of the myocardial lesions evoked by isoprenaline in the rat.
Godfraind T; Sturbois X
Arzneimittelforschung; 1979; 29(9a):1457-64. PubMed ID: 575492
[TBL] [Abstract][Full Text] [Related]
5. Protective action of creatinol O-phosphate against serum CPK activity enhanced by isoprenaline in the rat.
Marzo A; Ghirardi P
Arzneimittelforschung; 1979; 29(9a):1471-3. PubMed ID: 575495
[TBL] [Abstract][Full Text] [Related]
6. [Effects of creatinol O-phosphate on the isolated rabbit's atrium and on the rat's phrenic nerve diaphragm preparation].
Ferrini R; Miragoli G
Farmaco Sci; 1975 Nov; 30(11):912-6. PubMed ID: 1238289
[TBL] [Abstract][Full Text] [Related]
7. The prevention by creatinol O-phosphate of myocardial lesions evoked by isoprenaline.
Godfraind T; Sturbois X
Arch Int Pharmacodyn Ther; 1979 Feb; 237(2):288-97. PubMed ID: 573603
[TBL] [Abstract][Full Text] [Related]
8. Acute clinical tolerance of creatinol O-phosphate.
Melloni GF; Minoja GM; Lureti GF; Merlo L; Pamparana F; Brusoni B
Arzneimittelforschung; 1979; 29(9a):1447-9. PubMed ID: 575490
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
Osada E; Murai T; Ishizaka Y; Sanai K
Arzneimittelforschung; 1984; 34(11A):1641-51. PubMed ID: 6152157
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of creatinol O-phosphate (COP) on some experimental arrhythmias in vitro and in vivo.
Ferrini R; Miragoli G
Arzneimittelforschung; 1979; 29(9a):1475-7. PubMed ID: 575497
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and chemical properties of N- and O-phosphorylated derivatives of creatinol.
Ferrari G; Casagrande C
Arzneimittelforschung; 1979; 29(9a):1446-9. PubMed ID: 575489
[TBL] [Abstract][Full Text] [Related]
12. [Effects of creatinol-O-phosphate on left ventricular function in coronary disease patients].
Cucchini F; Colla B; Di Donato M; Visioli O
Boll Soc Ital Cardiol; 1978; 23(3):527-32. PubMed ID: 572691
[No Abstract] [Full Text] [Related]
13. Effects of creatinol-O-phosphate (COP) on haemodynamics and cardiac metabolism in conscious and anaesthetized dogs.
Marchetti G; Merlo L
Arzneimittelforschung; 1978; 28(10):1708-11. PubMed ID: 582673
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
Hirohashi M; Takasuna K; Yamashita N; Tamura K
Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573
[TBL] [Abstract][Full Text] [Related]
15. Effects of creatinol O-phosphate on serum enzymes in acute myocardial infarction.
Knippel M; Bana G; Pusterla GL
Arzneimittelforschung; 1979; 29(9a):1480-2. PubMed ID: 575498
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of creatinol O-phosphate (COP) on ventricular fibrillation and death induced by intravenous CaCl2 in mice.
Ferrini R; Miragoli G
Arzneimittelforschung; 1979; 29(9a):1473-4. PubMed ID: 575496
[TBL] [Abstract][Full Text] [Related]
17. Possible mechanism of the negative inotropic effect of alpha1-adrenoceptor agonists in rat isolated left atria after exposure to free radicals.
Peters SL; Batink HD; Michel MC; Pfaffendorf M; van Zwieten PA
Br J Pharmacol; 1998 Mar; 123(5):952-8. PubMed ID: 9535025
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological and toxicological properties of creatinol O-phosphate. A review.
Marzo A; Ghirardi P
Arzneimittelforschung; 1979; 29(9a):1449-52. PubMed ID: 395957
[TBL] [Abstract][Full Text] [Related]
19. Chronotropic and inotropic responses to ASL-7022 on isolated rat atria.
Gende OA; Camilión de Hurtado MC
Acta Physiol Pharmacol Latinoam; 1989; 39(2):119-26. PubMed ID: 2618750
[TBL] [Abstract][Full Text] [Related]
20. Effects of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl] -2(1H)-quinolinone (OPC-8212), a new inotropic agent, on cardiotonic activity and coronary hemodynamics.
Inoue M; Hori M; Nakajima S; Kitakaze M; Fukunami M; Ishida Y; Abe H
Arzneimittelforschung; 1984; 34(3A):355-9. PubMed ID: 6540088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
